The lack of medicine at public hospitals has caused concern among the public. The Prime Minister has instructed the Ministry of Finance (MOF) and relevant ministries to find solutions to resolve the problem.

While Vietnam’s drugmakers are heading to develop new products to increase efficiency and sustain sustainable growth, competition from imported drugs is making their road tougher.

With the average pharmaceutical import turnover of $245 million per month, the figure of the whole year of 2019 may reach $3 billion, equaling 50 per cent of the whole scale of the market.  

According to the service commitments form of the WTO, Vietnam did not commit to allow foreign invested enterprises to conduct drug distribution services.

Although having import licenses in hands, the road for multi-national corporations to trade drugs in Vietnam remains tough because of legal limitations.

VietNamNet Bridge - The pharmaceutical industry is expected to see big changes this year thanks to investments from both Vietnamese and foreign companies.

FPT Retail, the digital device retailer, The Gioi Di Dong, the biggest smartphone distributor, and Vingroup, the real estate developer and retailer, all have spent big money to set up their drug retail and manufacturing chains.

Giant retailers who have been eyeing the drug retail market for years have finally joined the game with ambitious plans to remap the market.

VietNamNet Bridge - The Vietnamese drug market, valued at $5.2 billion, is attracting more foreign investors and multinationals.

Vietnam runs up trade deficit in March; Lao company markets coffee in Vietnam; Japan steps up inspection of shrimp imports; Another Amway factory shaping up in Binh Duong; Vietnam bond issues grow fastest in East Asia

 VietNamNet Bridge – Signs of violation of the Competition Law have emerged in the pharmaceutical market of Vietnam, said Nguyen Phuong Nam, deputy director general of the Vietnam Competition Authority under the Ministry of Industry and Trade.